""

Assistant Professor This email address is being protected from spambots. You need JavaScript enabled to view it.
Volker G082 C4
(205) 934-3116

Research and Teaching Interests: Cancer imaging, drug delivery, tumor microenvironment, precision oncology

Office Hours: By appointment

Education:

  • B.S., Mississippi State University, Biological Engineering
  • M.S., University of Alabama at Birmingham, Biomedical Engineering
  • Ph.D., University of Alabama at Birmingham, Biomedical Engineering
  • Post-doc, Vanderbilt University, Department of Radiology, Vanderbilt University Institute of Imaging Science

Dr. Sorace comes from the University of Texas at Austin in 2019 where she was an Assistant Professor in the Departments of Diagnostic Medicine, Oncology, and Biomedical Engineering. Her broad research interests include improving cancer patient care through translational advancements in cancer imaging. She has expertise in multimodality, non-invasive quantitative imaging to improve detection, monitoring and therapy of cancer in both preclinical animal models and clinical cancer research.

The overall goal of Dr. Sorace’s research is to identify imaging biomarkers for early response to neoadjuvant and adjuvant cancer treatment and utilize quantitative imaging to guide and improve drug delivery of current therapies in cancer. She moved back to Birmingham with her husband, Anthony, and their two daughters.

Select Publications

  • Sorace AG, Wu C, Jarrett A, Avery S, Patt D, Goodgame B, Luci J, Kang J, Abramson R, Yankeelov TE, Virostko J. Repeatability, reproducibility, and accuracy of quantitative MRI of the breast in the community setting. JMRI. 2018.
  • Sorace AG, Partridge SC, Li X, Virostko J, Barnes SL, Huang W, Yankeelov TE. Quantitative and Semi-quantitative Analysis of High Temporal Resolution DCE-MRI Data for Distinguishing Benign and Malignant Breast Tumors: A Retrospective Analysis of the IBMC 6883 Multi-Institutional Trial Data. JMI. 2018.
  • Syed A, McIntyre JO, Whisenant JW, Yankeelov TE, Sorace AG. Measuring alterations in intratumoral heterogeneity in response to trastuzumab therapy in preclinical models of HER2+ breast cancer using quantitative in vivo imaging and immunohistochemistry. Neoplasia. 2018.
  • Jarrett AM, Ekrut D, Godfrey W, Bloom M, Syed A, Ehrlich LI, Yankeelov TE, Sorace AG. Mathematical modeling of anti-Her2 therapy-induced immune response in HER2+ breast cancer in an in vivo murine model of breast cancer. Mathematical Biology and Medicine. 2018.
  • Virostko J, Hainline A, Kang H, Arlinghaus LR, Abramson RG, Barnes SL, Blume JD, Avery S, Patt D, Goodgame B, Yankeelov TE, Sorace AG. DCE-MRI and DW-MRI for Predicting the Response of Locally Advanced Breast Cancer to Neoadjuvant Therapy: A Meta-Analysis. JMI. 2018.
  • Sorace AG, Syed AK, Quarles CC, Barnes SL, Sanchez V, Kang H, Yankeelov TE. Quantitative 18F-FMISO-PET imaging shows reduction of hypoxia following trastuzumab in a murine model of HER2+ breast cancer. Molecular Imaging and Biology. 2017 Feb (1):130-137.
  • Sorace AG, Quarles CC, Whisenant JG, Hanker AB, McIntyre JO, Sanchez VM, Yankeelov TE. Quantitative assessment of improved vascular delivery and treatment response following trastuzumab in a murine model of HER2+ breast cancer. Breast Cancer Research and Treatment. 2016 Jan 155 (2):273-284.

Academic Distinctions and Professional Societies

  • American Association for Cancer Research
  • International Society of Magnetic Resonance in Medicine